|
Title
|
Publication Date
|
Price
|
Relevance
|
|
Transforming Drug Discovery through Genomics and Proteomics
|
Jan 2009 |
£155 |
100% |
Innovations in Bioinformatics Emerging Tools for Drug Discovery and Development
|
Jan 2008 |
£2,425 |
97% |
|
Biomarkers: Technologies and Global Markets
|
Mar 2011 |
£3,065 |
92% |
|
Companion Biomarkers in Drug Development
|
Apr 2009 |
£2,150 |
88% |
|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
Sep 2011 |
£2,150 |
85% |
|
Preventive Healthcare Technologies, Products and Markets
|
Oct 2009 |
£3,065 |
85% |
|
Mass Spectroscopy for Clinical Laboratory Analysis
|
Nov 2011 |
£2,150 |
83% |
Biomarkers (2 parts) Technologies, Markets and Companies
|
Jan 2012 |
£3,240 |
83% |
|
Market for Bioengineered Protein Drugs; The
|
Jan 2007 |
£2,760 |
80% |
Multiplex Assays Evolving Technologies, Applications and Future Directions
|
Jan 2010 |
£2,370 |
76% |
|
Companion Diagnostics in Personalized Medicine and Cancer Therapy
|
Jul 2011 |
£2,150 |
71% |
|
Central and Core Laboratories
|
Oct 2007 |
£995 |
70% |
|
Flow Cytometry: Products, Technologies and Global Markets
|
Jun 2011 |
£3,065 |
69% |
|
Central and Core Laboratories
|
Oct 2011 |
£1,195 |
67% |
|
200 China-based Best CROs and CMOs
|
Mar 2009 |
£950 |
65% |
|
Global Medical Markets for Nanoscale Materials and Devices
|
Jan 2008 |
£3,065 |
65% |
Alzheimer's disease Technologies, Markets and Companies
|
Jan 2012 |
£2,265 |
64% |
Top 10 Biotech Companies Market Outlook, 2008-2023
|
Jan 2009 |
£1,499 |
64% |
|
Lateral Flow Technology and the Future of Point of Care Diagnostics
|
Feb 2007 |
£1,895 |
64% |
Drug Approval Trends at the FDA and EMEA Process Improvements, Heightened Scrutiny and Industry Response
|
Apr 2008 |
£2,425 |
60% |
|
Gene Expression Profiling Markets
|
Jan 2008 |
£2,525 |
60% |
|
Key Diagnostic Testing Markets
|
Dec 2004 |
£630 |
59% |
Nanobiotechnology (2 parts) Applications, Markets and Companies
|
Jan 2012 |
£3,240 |
59% |
|
Top 100 Best Pharma Outsourcing Service Providers in China and India
|
Jul 2009 |
£600 |
58% |
|
Global Markets for In Vitro Toxicity Testing
|
Sep 2010 |
£3,065 |
58% |
Advances in the Use of Biomarkers in Biochip and Microarray Testing Innovative technologies, growth opportunities and the future market outlook
|
Oct 2009 |
£2,425 |
57% |
|
HighGrowth Diagnostic Markets
|
Nov 2008 |
£2,150 |
55% |
|
Molecular Diagnostics: Major World Markets
|
Feb 2007 |
£2,525 |
55% |
DNA sequencing Technologies, Markets and Companies
|
Jan 2012 |
£1,815 |
54% |
|
Molecular Diagnostics Markets
|
Jul 2011 |
£2,150 |
54% |